Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 14, 2020; 26(14): 1546-1553
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1546
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1546
Table 1 Gastrointestinal manifestations of coronavirus disease 2019
Manifestation | Reported prevalence | |
Luminal | ||
Diarrhea | Very common | 10%-29%, potentially 50% in North America |
Abdominal pain | Common | 1%-29% |
Nausea and vomiting | Common | 1%-29% |
Hemorrhagic enterocolitis | Rare | Case report |
Liver | ||
Acute liver failure | So far not reported | |
Mild to moderately elevated AST and ALT | Very Common | 17%-62% |
Elevated bilirubin | Uncommon | Up to 11% |
Elevated alkaline phosphatase | Uncommon | < 5% |
Elevated GGT | Common | Up to 54% |
- Citation: Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F, Brown Jr RS, Carr-Locke D, Cohen DE, Sharaiha RZ. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol 2020; 26(14): 1546-1553
- URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1546.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1546